COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 5/Signature 2
From BugSigDB
< COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition | COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 5(Redirected from COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 5/Signature 2)
Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15
Source: Supplementary Table 3
Description: Differential abundance of mothers one week after second dose of BNT162b2 when compared to baseline.
Abundance in Group 1: decreased abundance in Mothers at one week post-second dose
Revision editor(s): ChiomaBlessing, WikiWorks